These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33725637)

  • 1. Biology of interleukin-38 and its role in chronic inflammatory diseases.
    Xia HS; Liu Y; Fu Y; Li M; Wu YQ
    Int Immunopharmacol; 2021 Jun; 95():107528. PubMed ID: 33725637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-36 receptor antagonist with special emphasis on IL-38.
    Shaik Y; Sabatino G; Maccauro G; Varvara G; Murmura G; Saggini A; Rosati M; Conti F; Cianchetti E; Caraffa A; Antinolfi P; Pandolfi F; Potalivo G; Galzio R; Conti P; Theoharides TC
    Int J Immunopathol Pharmacol; 2013; 26(1):27-36. PubMed ID: 23527706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IL-38 and its related cytokines in inflammation.
    Yuan X; Peng X; Li Y; Li M
    Mediators Inflamm; 2015; 2015():807976. PubMed ID: 25873772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
    Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
    Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-24 Immunobiology and Its Roles in Inflammatory Diseases.
    Zhong Y; Zhang X; Chong W
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enigmatic role of IL-38 in inflammatory diseases.
    Garraud T; Harel M; Boutet MA; Le Goff B; Blanchard F
    Cytokine Growth Factor Rev; 2018 Feb; 39():26-35. PubMed ID: 29366546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Interleukin-32 in autoimmunity.
    de Albuquerque R; Komsi E; Starskaia I; Ullah U; Lahesmaa R
    Scand J Immunol; 2021 Feb; 93(2):e13012. PubMed ID: 33336406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38.
    Clavel G; Thiolat A; Boissier MC
    Joint Bone Spine; 2013 Oct; 80(5):449-53. PubMed ID: 23849463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-27: a double agent in the IL-6 family.
    Jones GW; Hill DG; Cardus A; Jones SA
    Clin Exp Immunol; 2018 Jul; 193(1):37-46. PubMed ID: 29437229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-19 and Other IL-20 Family Member Cytokines in Vascular Inflammatory Diseases.
    Autieri MV
    Front Immunol; 2018; 9():700. PubMed ID: 29681905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
    Leng RX; Pan HF; Tao JH; Ye DQ
    Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 family cytokines in chronic inflammatory disorders.
    Stříž I
    Vnitr Lek; 2019; 65(2):81-85. PubMed ID: 30909697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of inflammation in immune and nonimmune cells by interleukin-19.
    Leigh T; Scalia RG; Autieri MV
    Am J Physiol Cell Physiol; 2020 Sep; 319(3):C457-C464. PubMed ID: 32667867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-19 as a potential therapeutic in autoimmune and inflammatory diseases.
    Azuma YT; Nakajima H; Takeuchi T
    Curr Pharm Des; 2011 Nov; 17(34):3776-80. PubMed ID: 22103848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
    Ge Y; Huang M; Yao YM
    Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress in the pathophysiological role of interleukin-19].
    Fujimoto Y; Azuma YT
    Nihon Yakurigaku Zasshi; 2019; 154(2):66-71. PubMed ID: 31406045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 32, inflammation and cancer.
    Hong JT; Son DJ; Lee CK; Yoon DY; Lee DH; Park MH
    Pharmacol Ther; 2017 Jun; 174():127-137. PubMed ID: 28223235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22 and inflammation: leukin' through a glass onion.
    Zenewicz LA; Flavell RA
    Eur J Immunol; 2008 Dec; 38(12):3265-8. PubMed ID: 19016525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interleukins and their inhibitors in the development of autoimmune uveitis.
    Kuryltsiv NB; Halei KM
    Wiad Lek; 2019; 72(4):716-722. PubMed ID: 31055563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-33: a novel mediator with a role in distinct disease pathologies.
    Kurowska-Stolarska M; Hueber A; Stolarski B; McInnes IB
    J Intern Med; 2011 Jan; 269(1):29-35. PubMed ID: 21158975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.